Side Effects After Direct-acting Antiviral Treatment

Hospices Civils de Lyon95 enrolled

Overview

The objective of this study was to assess the incidence of side effects after direct-acting antiviral therapy in patients with chronic hepatitis C virus infection.

Direct-acting antiviral (DAA)-based treatments are today very effective The objective of this study was to assess the incidence of side effects after DAA therapy in patients with chronic hepatitis C virus infection.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Chronic Hepatitis c

Interventions

DAA treatmentDRUG

Direct-acting antiviral-based treatment

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age or older * Hepatitis C virus infection * Treatment by direct-acting antiviral combination Exclusion Criteria: * HIV coinfection

Locations (1)

Croix-Rousse Hospital, Hospices Civils de Lyon

Lyon, France

Outcomes

Primary Outcomes

Incidence of side effects

Incidence of side effects occurring during treatment duration. Treatment duration may be of 8 weeks, 12 weeks or 24 weeks depending on treatment combination.

Time frame: Within treatment duration, i.e. 8, 12 or 24 weeks after treatment initiation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.